top of page

Free Biopharma Daily Stock Updates - 06/17/21

  • Writer: BPIQ
    BPIQ
  • Jun 17, 2021
  • 2 min read

$XBI +$134.4 +0.59%


Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!

Covid Updates

$TLSA +6.3% Tiziana Responds to UK Call for Development of Innovative 'Take Home' Treatments for COVID-19 Disease. source



Pipeline Updates

$AMPE -0.6% Ampio Provides Update on Osteoarthritis of the Knee (OAK) Program, Reiterates Compelling Data in Earlier Phase III Trials of Ampion in Severe OAK. source


$ACRX +2.9% Announces Agreement with FDA Addressing the Warning Letter Received for DSUVIA® Promotional Materials. source


$TPTX +3.8% Turning Point Therapeutics Granted FDA Orphan Drug Designation for TPX-0022 in Gastric Cancer. source


$AGEN +6.4% Agenus Announces U.S. FDA Acceptance and Priority Review of Balstilimab Biologics License Application for the Treatment of Recurrent or Metastatic Cervical Cancer. source


$PHAS +0.8% PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab. source


$AMRX -3.6% Amneal Announces U.S. FDA Filing Acceptance of Biologics License Application (BLA) for Bevacizumab. source


$SYBX +5.6% Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease. source


$VKTX +5.3% Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Novel Oral Thyroid Receptor Beta Agonist VK0214. source


$HZNP +1.4% Horizon Therapeutics plc Announces Purchase of Manufacturing Facility to Support Growth of On-Market Rare Disease and Pipeline Biologics. source


$FGEN +1.7% FibroGen and HiFiBiO Announce Transformative Partnership to Advance Next-Generation Therapies for Patients with Cancer and Autoimmune Disease. source


$OPK +1.9% OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland. source


$APLT +3.3% Applied Therapeutics Granted Fast Track Designation by FDA for AT-007 for Galactosemia. source


$EGRX +3.2% Eagle Pharmaceuticals Submits Response to Complete Response Letter from FDA for Vasopressin. source


$AERI +0.6% Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in Japan. source


$IRWD 0% Ironwood Pharmaceuticals Announces That The American Journal of Gastroenterology Publishes Full Results from Positive LINZESS® (linaclotide) Phase IIIb Trial in Adults with Irritable Bowel Syndrome with Constipation (IBS-C). source


$PRTA -15.5% Participated in JMP Securities Life Sciences Conference on 6/16/21. source


$CLSD +13.8% On 6/15 Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD. source


$CAPR +15.0% Participating in BIO Digital 2021 June 14-18.



Financial Updates

$JAZZ -1.9% Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently Acquired GW Pharmaceuticals plc. source


$NOVN -21.7% Novan Announces Pricing of $40 Million Public Offering of Common Stock. source

Posted by FS

 
 
 

Comments

bottom of page